Wednesday, February 10, 2010, 8:40am EST - Canadian Markets open in 50 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Smith & Nephew plc (SNN)

 On Feb 9: 50.24 USD   0.00 (0.00%)  
MORE ON SNN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SMITH&NEPHEW PLC NEW (NYSE:SNN) Delayed quote dataEdit
Last Trade: 50.24 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 50.24
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 52.50
Day's Range: N/A - N/A
52wk Range: 30.01 - 53.66
Volume: 0
Avg Vol (3m): 86,725.4
Market Cap: 8.87B
P/E (ttm): 19.32
EPS (ttm): 2.60
Div & Yield: 0.68 (1.35%)
Smith & Nephew plc (SNN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add SNN to Portfolio   Download Data

HEADLINES
• Conmed Surpasses Zacks Estimate
Zacks.com (Mon, Feb 8)
• Smith & Nephew upgraded by UBS
Briefing.com (Mon, Feb 8)
• International NPWT Expert Panel Convenes in Hamburg
PRNewswire (Wed, Feb 3)
• Smith & Nephew Endoscopy Awarded Contract From Healthtrust Purchasing Group
PRNewswire (Mon, Feb 1)
• 2010 Recovery In Capital Expenditures By Hospitals Will Benefit Specific Medical Equipment Sectors According To 14 Year Industry Veteran
Wall Street Transcript (Mon, Jan 25)
• More British Stocks To Consider
at Investopedia (Mon, Jan 25)
• Smith & Nephew donates medical equipment to Haiti
AP (Wed, Jan 20)
• Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
PRNewswire (Wed, Jan 20)
• Stryker Reports Preliminary Results
Zacks.com (Thu, Jan 14)
• Stryker Completes Acquisition
Zacks.com (Mon, Jan 4)
• Relocation Cost for Wright
Zacks.com (Tue, Dec 29)
• Smith & Nephew completes purchase of Nucryst
AP (Tue, Dec 22)
• Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.
PRNewswire (Tue, Dec 22)
• PILOTs approved for Nike, Smith & Nephew
at bizjournals.com (Wed, Dec 16)
More Headlines for SNN...
ANALYST
EPS Est (next year) (Dec-09) : 2.99
EPS Est (in 2 years) (Dec-10) : 3.35
Avg Rec (current)*: 3.2
PEG Ratio: 1.49
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, marketing, and sale of medical devices worldwide. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices